UraniumX increases LIFE offering to $4.31-million

Executive Summary

• UraniumX Discovery Corp. upsized its previously announced listed issuer financing exemption (LIFE) offering to up to 21.55 million units for gross proceeds of up to $4.31 M.
• Each unit contains one common share and one warrant (exercise price $0.30, exercisable after 60 days, 36‑month term).
• The company also announced a separate flow‑through offering of 4,444,444 shares at $0.225 per share for up to $1 M in gross proceeds.

Key Details

• Original LIFE Offering (announced Jan 22 & Feb 10, 2026): 20 M units @ $0.20/unit → up to $4 M gross proceeds.
• Upsized LIFE Offering: increased to 21.55 M units @ $0.20/unit → $4.31 M gross proceeds.
• Unit composition: 1 common share + 1 common share purchase warrant.
• Warrant terms: right to acquire one additional common share at $0.30/share, exercisable beginning 60 days after closing, valid for 36 months.
• Closing date: expected Feb 13, 2026 (or earlier/later at company’s discretion), subject to CSE and regulatory approvals.
• Use of proceeds – LIFE offering: general working capital, corporate purposes, and exploration/development on Murphy Lake, Zoo Bay, and NeoCore uranium properties in Saskatchewan’s Athabasca Basin.
• Flow‑through share offering: 4,444,444 shares @ $0.225/share → up to $1 M gross proceeds; may involve finder’s fees.
• Use of flow‑through proceeds: eligible Canadian exploration expenses qualifying as flow‑through mining expenditures under the Income Tax Act for Canadian projects.
• Hold period: Flow‑through shares subject to a statutory hold period of 4 months + 1 day.
• Regulatory framework: Both offerings conducted under NI 45‑106 Part 5A listed issuer financing exemption; LIFE units not subject to statutory hold period, flow‑through shares are.

Notable Quotes

(No direct quotes were provided in the release.)